Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 6 of 6 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
ADRA2A
💬1. ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬1. ADRA2A
| Dexmedetomidine | [14] 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬1. ADRA2A
| ||||||||||||||||||||||||||||||||||||||
| 2 |
ADRA2B
💬2. ADRA2B
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬2. ADRA2B
| Dexmedetomidine | [14] 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬2. ADRA2B
| ||||||||||||||||||||||||||||||||||||||
| 3 |
ADRA2C
💬3. ADRA2C
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬3. ADRA2C
| Dexmedetomidine | [14] 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬3. ADRA2C
| ||||||||||||||||||||||||||||||||||||||
| 4 |
PTGS2
💬4. PTGS2
| [22] Arachidonic acid metabolism Arachidonic acid metabolism, Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, C-type lectin receptor signaling pathway, IL-17 signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Alzheimer disease, Pathways of neurodegeneration - multiple diseases, Leishmaniasis, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Pathways in cancer, Chemical carcinogenesis - DNA adducts, MicroRNAs in cancer, Small cell lung cancer [22] Arachidonic acid metabolism, Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling p ... | Celecoxib
Celecoxib
💬4. PTGS2
| Celecoxib | [10] 2 2, 3, 34, 46, 70, 89, 107, 161, 171, 271 💬
| ||||||||||||||||||||||||||||||||||||||
| 5 |
SLC6A2
💬5. SLC6A2
| [1] Synaptic vesicle cycle Synaptic vesicle cycle | Bupropion
Bupropion
💬5. SLC6A2
| Bupropion | [5] 8 8, 18, 21, 96, 171 💬
| ||||||||||||||||||||||||||||||||||||||
| 6 |
SLC6A3
💬6. SLC6A3
| [7] Synaptic vesicle cycle Synaptic vesicle cycle, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Alcoholism [7] Synaptic vesicle cycle, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - ... | Bupropion
Bupropion
💬6. SLC6A3
| Bupropion | [5] 8 8, 18, 21, 96, 171 💬
|